Evidence map›Paper›PMID 38702791›Full record

ArticleBMC chemistry2024

Two-point immobilization of M3 muscarinic receptor: a method for recognizing receptor antagonists in natural products.

Xiaomin Huang, Ting Wang, Ludan Wang, Yantao Sun, Ziru Zhang, Yajun Zhang

Abstract read
In one paragraph

Article in BMC chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaomin HuangKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Ministry of Life Sciences and Medicine, Northwest University, Xi'an, 710069, China.
Ting WangKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Ministry of Life Sciences and Medicine, Northwest University, Xi'an, 710069, China.
Ludan WangKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Ministry of Life Sciences and Medicine, Northwest University, Xi'an, 710069, China.
Yantao SunKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Ministry of Life Sciences and Medicine, Northwest University, Xi'an, 710069, China.
Ziru ZhangKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Ministry of Life Sciences and Medicine, Northwest University, Xi'an, 710069, China.
Yajun ZhangKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Ministry of Life Sciences and Medicine, Northwest University, Xi'an, 710069, China. zhangyj@nwu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the investigation of active ingredients from natural products, current technologies relying on drug-target affinity recognition analysis face significant challenges. This is primarily due to their limited specificity and inability to provide downstream pharmacodynamic information, such as agonistic or antagonistic activity. In this study, a two-point method was developed by immobilizing M3 acetylcholine receptor (M3R) through the combination of the conformation-specific peptide BJ-PRO-13a and the HaloTag trap system. We systematically assessed the specificity of the immobilized M3R using known M3R antagonists (pirenzepine and atropine) and agonists (cevimeline and pilocarpine). By frontal analysis and nonlinear chromatography, the performance of immobilized M3R was evaluated in terms of binding kinetics and thermodynamics of four drugs to the immobilized M3R. Additionally, we successfully identified two M3R antagonists within an extract from Daturae Flos (DF), specifically hyoscyamine and scopolamine. Our findings demonstrate that this immobilization method effectively captures receptor-ligand binding interactions and can discern receptor agonists from antagonists. This innovation enhances the efficiency of receptor chromatography to determine binding-affinity in the development of new drugs, offering promise for the screening and characterization of active compounds, particularly within complex natural products.

Indexed as

BiochromatographyBJ-PRO-13a peptideDrug discoveryImmobilized M3 muscarinic receptorsNatural products

Identifiers

PMID38702791
PMCPMC11069257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.